High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder

American Journal of Psychiatry

Volumn 156, Issue 8, 1999, Pages 1209-1215

  Ernst, Monique ^a,b,c   Zametkin, Alan J ^a   Matochik, John A ^a   Pascualvaca, Daisy ^a   Jons, Peter H ^a   Cohen, Robert M ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPA; FLUORINE 18; DIAGNOSTIC AGENT; DOPAMINE; DRUG DERIVATIVE; FLUORINE; FLUORODOPA F 18;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MESENCEPHALON; NERVE ENDING; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; CHEMISTRY; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FRONTAL LOBE; HEMISPHERIC DOMINANCE; HOSPITALIZATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTISCANNING; SYNAPTOSOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAUDATE NUCLEUS; CHILD; DIHYDROXYPHENYLALANINE; DOPA DECARBOXYLASE; DOPAMINE; FEMALE; FLUORINE RADIOISOTOPES; FRONTAL LOBE; FUNCTIONAL LATERALITY; HUMANS; MALE; MESENCEPHALON; PRESYNAPTIC TERMINALS; PUTAMEN; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032587158     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Castellanos FX, Elia J, Kruesi MJP, Marsh WL, Gulotta CS, Potter WZ, Ritchie GF, Hamburger SD, Rapoport JL: Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention-deficit/hyperactivity disorder. Neuropsychopharmacology 1996; 14:125-137
2. Sherry T, Chase TN: Central monoamines and hyperkinesis of childhood. Neurology 1976; 26:1000-1002
3. Shaywitz BA, Cohen DJ, Bowers MBJ: CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine: a preliminary report. J Pediatr 1977; 90:67-71
4. Cohen DJ, Caparulo BK, Shaywitz BA, Bowers MB: Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 1977; 34:545-550
5. Shekim WO, Javaid J, Davis JM, Bylund DB: Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biol Psychiatry 1983; 18:707-714
6. Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ: Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997; 16:276-284
7. Reimherr FW, Wender PH, Ebert MH, Wood DR: Cerebrospinal fluid homovanillic acid and 5-hydroxyindolacetic acid in adults with attention deficit hyperactivity disorder, residual type. Psychiatry Res 1984; 11:71-78
8. Aylward EH, Reiss AL, Reader MJ: Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996; 11:112-115
9. Castellanos FX, Giedd JN, Marsh WL: Quantitative brain magnetic resonance imaging in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1996; 53:607-616
10. Hynd GW, Hern KL, Novey ES: Attention deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993; 8:339-347
11. Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J, Hamburger S, Cohen RM: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 323:1361-1366
12. Zametkin A, Liebenauer L, Fitzgerald G, King A, Minkunas D, Herscovitch P, Yamada E, Cohen R: Brain metabolism in teenagers with attention deficit hyperactivity disorder. Arch Gen Psychiatry 1993; 50:333-340
13. Ernst M, Liebenauer LL, King AC, Fitzgerald GA, Cohen RM, Zametkin AJ: Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994; 33:858-868
14. Ernst M, Zametkin AJ, Matochik JA, Liebenauer L, Fitzgerald GA, Cohen RM: Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD): preliminary findings. Psychopharmacol Bull 1994; 30:219-225
15. Matochik JA, Nordahl TE, Gross M, Semple WE, King AC, Cohen RM, Zametkin AJ: Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 1993; 8:377-386
16. Matochik JA, Liebenauer LL, King C, Szymanski HV, Cohen RM, Zametkin AJ: Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994; 151:658-664
17. Ernst M, Zametkin AJ, Matochik JA, Schmidt M, Liebenauer LL, Jons PH, Hardy K, Cohen RM: Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 1997; 17:391-401
18. Cook EH, Stein MA, Krasowski MD: Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56:993-998
19. LaHoste GJ, Swanson JM, Wigal SB: Dopamine D4 receptor gene polymorphisms associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1:121-124
20. Cumming P, Gjedde A: Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse 1998; 29:37-61
21. Reich W, Welner Z: Diagnostic Interview for Children, Adolescents, and Parents. St Louis, Washington University, 1988
22. Zametkin AJ, Schwartz DJ, Ernst ME, Cohen RM: Is research in normal and ill children involving radiation exposure ethical? (letter). Arch Gen Psychiatry 1996; 53:1060-1061
23. Ernst M, Freed ME, Zametkin AJ: Health hazards of radiation exposure in the context of brain imaging research: special consideration for children. J Nucl Med 1998; 39:689-698
24. Woodcock RW, Johnson BB: Woodcock-Johnson Psychoeducational Battery Examiner's Manual. Allen, Tex, DLM Teaching Resources, 1977
25. Jastak S, Wilkinson GS: The Wide Range Achievement Test, Revised. Wilmington, Del, Jastak Associates, 1984
26. Wechsler D: WISC-R Manual: Wechsler Intelligence Scale for Children-Revised. New York, Psychological Corp, 1974
27. Achenbach TM, Edelbrock C: Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington, University of Vermont, Department of Psychiatry, 1983
28. Goyette CH, Conners CK, Ulrich RF: Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 1978; 6:221-236
29. Ullmann RK, Sleator EK, Sprague RL: Introduction to the use of ACTeRS. Psychopharmacol Bull 1985; 21:915-920
30. Gershon ES, DeLisi LE, Hamovit J, Nurnberger JIJ, Maxell ME, Schreiber J, Dauphinais D, Dingman CWI, Guroff JJ: A controlled family study of chronic psychosis. Arch Gen Psychiatry 1988; 45:328-336
31. McLellan C, Doudet D, Brucke T, Aigner T, Cohen R: New rapid analysis method demonstrates differences in 6-[18-F]Fluoro-L-DOPA plasma input curves with and without carbidopa in hemi-MPTP lesioned monkeys. Appl Radiat Isot 1991; 42:847-854
32. Doudet DJ, McLellan CA, Aigner TG, Wyatt RJ, Cohen RM: Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-DOPA uptake in brain. J Nucl Med 1992; 33: 1383-1389
33. Matsui T, Hirano A: An Atlas of the Human Brain for Computerized Tomography. New York, Igaku-Shoin, 1978
34. Semple WE, Johnson JL, Cohen RM: Reliability in positron emission tomographym, in Imaging Drug Action in the Brain. Edited by London ED. Boca Raton, Fla, CRC Press, 1993, pp 297-316
35. Doudet DJ, Aigner TG, McLellan CA, Cohen RM: Positron emission tomography with 18-F-DOPA: interpretation and biological correlates in non-human primates. Psychiatry Res 1992; 45:153-168
36. Ernst M, Zametkin A, Matochik J, Pascualvaca D, Jons P, Hardy K, Hankerson J, Doudet D, Cohen R: Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996; 334:1568-1604
37. Torstenson R, Hartvig P, Langstrom B, Westerberg G, Tedroff J: Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease. Ann Neurol 1997; 41:334-440
38. Abercrombie ED, Bonatz AE, Zigmond MJ: Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 1990; 525:36-44
39. Zhu MY, Jurio AV, Paterson I, Boulton AA: Regulation of striatal L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur J Pharmacol 1993; 238: 157-164
40. Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH: Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem 1993; 60:2175-2180
41. Sivam SP: Dopaminergic regulation of postnatal development of dynorphin neurons in rat striatum. Neuropeptides 1996; 30: 103-107
42. Schmidt U, Beyer C, Oestreicher AB, Reisert I, Schilling K: Pilgrim C activation of dopaminergic D1 receptors promotes morphogenesis of developing striatal neurons. Neuroscience 1996; 74:453-460
43. Penit-Soria J, Durand C, Herve D, Besson MJ: Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats. Neuroscience 1997; 77:753-766
44. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH: New evidence for neurotransmitter influences on brain development. Trends Neurosci 1997; 20:269-274
45. Blanchard V, Anglade P, Dziewczapolski G, Savasta M, Agid Y, Raisman-Vozari R: Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res 1996; 19:319-325
46. Alexander GE, Crutcher MD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13:266-271
47. Gerfen CR: The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 1992; 15:133-139
48. Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Karoum F, Potter WZ, Ismond D: Treatment of hyperactive children with monoamine oxidase inhibitors. Arch Gen Psychiatry 1985; 42: 969-973
49. Trott GE, Friese HJ, Menzel M, Nissen G: Use of moclobemide in children with attention deficit hyperactivity disorder. Psychopharmacology (Berl) 1992; 196:134-136
50. Voeller KKS, Heilman KM: Attention deficit disorder in children: a neglect syndrome? Neurology 1988; 38:806-808
51. Malone MA, Kershner JR, Swanson JM: Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. J Child Neurol 1994; 9:181-189
52. Gross-Tsur V, Shalev RS, Manor O, Amir N: Developmental right-hemisphere syndrome: clinical spectrum of the nonverbal learning disability. J Learn Disabil 1995; 28:80-86
53. Campbell L, Malone MA, Kershner JR, Roberts W, Humphries T, Logan WJ: Methylphenidate slows right hemisphere processing in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 1996; 6:229-239